Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001571169 | SCV001795589 | uncertain significance | not provided | 2024-03-12 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function |
Labcorp Genetics |
RCV001571169 | SCV002157534 | benign | not provided | 2024-01-16 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001571169 | SCV003831148 | uncertain significance | not provided | 2021-08-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004039368 | SCV004926761 | uncertain significance | Inborn genetic diseases | 2024-01-19 | criteria provided, single submitter | clinical testing | The c.3227G>A (p.R1076H) alteration is located in exon 42 (coding exon 42) of the COL11A1 gene. This alteration results from a G to A substitution at nucleotide position 3227, causing the arginine (R) at amino acid position 1076 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |